- Home
- WFG vs TFX Comparison
WFG vs TFX Comparison
Compare WFG & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFG
- TFX
- Stock Information
- Founded
- WFG 1955
- TFX 1943
- Country
- WFG Canada
- TFX United States
- Employees
- WFG N/A
- TFX N/A
- Industry
- WFG
- TFX Medical/Dental Instruments
- Sector
- WFG
- TFX Health Care
- Exchange
- WFG Nasdaq
- TFX Nasdaq
- Market Cap
- WFG 6.0B
- TFX 5.5B
- IPO Year
- WFG N/A
- TFX N/A
- Fundamental
- Price
- WFG $68.04
- TFX $120.44
- Analyst Decision
- WFG Strong Buy
- TFX Hold
- Analyst Count
- WFG 3
- TFX 9
- Target Price
- WFG $103.67
- TFX $141.57
- AVG Volume (30 Days)
- WFG 235.8K
- TFX 572.9K
- Earning Date
- WFG 10-22-2025
- TFX 10-30-2025
- Dividend Yield
- WFG 1.88%
- TFX 1.13%
- EPS Growth
- WFG N/A
- TFX N/A
- EPS
- WFG N/A
- TFX 4.18
- Revenue
- WFG $5,832,000,000.00
- TFX $3,041,342,000.00
- Revenue This Year
- WFG N/A
- TFX $10.42
- Revenue Next Year
- WFG $9.90
- TFX $10.58
- P/E Ratio
- WFG N/A
- TFX $28.90
- Revenue Growth
- WFG N/A
- TFX 1.11
- 52 Week Low
- WFG $66.36
- TFX $108.90
- 52 Week High
- WFG $102.40
- TFX $241.41
- Technical
- Relative Strength Index (RSI)
- WFG 42.31
- TFX 43.25
- Support Level
- WFG $67.45
- TFX $118.97
- Resistance Level
- WFG $70.30
- TFX $129.43
- Average True Range (ATR)
- WFG 1.56
- TFX 4.05
- MACD
- WFG 0.03
- TFX -0.39
- Stochastic Oscillator
- WFG 35.07
- TFX 29.28
About WFG West Fraser Timber Co. Ltd Common stock
West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the Southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is now one of the largest oriented strand board producers in the world.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.